Physician profile
Joseph Keith Izes
NPI 1346280633
$1,298.83
in general payments reported to CMS, 2019-2025
17 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.00 · 2020: $14.96 · 2021: $134 · 2022: $236 · 2023: $303 · 2024: $390 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $280.38 | 2023-2024 | Urolift |
| Astellas Pharma US INC | $217.99 | 2019-2023 | Myrbetriq |
| Urovant Sciences INC | $181.31 | 2021-2022 | |
| Janssen Biotech, INC. | $115.00 | 2025 | Rybrevant, Carvykti |
| Sumitomo Pharma America, INC. | $79.05 | 2023-2024 | Gemtesa |
| Edap Technomed INC | $68.42 | 2023 | |
| 180 Medical, INC. | $52.33 | 2022-2024 | |
| Photocure INC | $46.76 | 2023 | Cysview |
| Merck Sharp & Dohme LLC | $42.30 | 2023 | Keytruda, Lynparza |
| Pfizer INC. | $34.36 | 2022-2024 | |
| Abbvie INC. | $33.61 | 2021-2022 | |
| Smith+Nephew, INC. | $31.76 | 2024 | Stravix |
| Corcept Therapeutics | $29.10 | 2024 | Korlym |
| Novartis Pharmaceuticals Corporation | $25.90 | 2024 | |
| Boston Scientific Corporation | $22.40 | 2024 | Rezum Generator |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avation Medical, INC. | $21.11 | 2025 | Vivally System |
| Myovant Sciences INC. | $17.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Izes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.